COL1A1 and myocardial infarction: In a mouse model of myocardial infarction (MI), Künzel et al. described that mesalazine, an anti-inflammatory drug used to treat inflammatory bowel disease, could decrease perivascular myocardial collagen 1A1 (COL1A1) expression and perivascular fibrosis [151].